Claes Dahlgren

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

The free fatty acid 2 receptor regulates C5a induced neutrophil superoxide production and its sensitivity to inhibition by the antagonist avacopan.

The free fatty acid 2 receptor regulates C5a induced neutrophil superoxide production and its sensitivity to inhibition by the antagonist avacopan.

Journal: Frontiers in immunology
Published: January 25, 2026

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

Journal: British journal of pharmacology
Published: December 29, 2025

Free fatty acid receptor 2 allosterism is defined by cellular context.

Free fatty acid receptor 2 allosterism is defined by cellular context.

Journal: Cell communication and signaling : CCS
Published: December 11, 2025

Data showing effects of resolvin D5 on prostaglandin E2 mediated inhibition of fMet-Leu-Phe induced activation of the NADPH oxidase in human neutrophils.

Data showing effects of resolvin D5 on prostaglandin E2 mediated inhibition of fMet-Leu-Phe induced activation of the NADPH oxidase in human neutrophils.

Journal: Data in brief
Published: July 14, 2025

Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gαq-coupled receptors.

Disruption of the actin cytoskeleton with latrunculin A controls ATP-induced NADPH oxidase activity and the recruitment of G proteins by neutrophil Gαq-coupled receptors.

Journal: Cellular signalling
Published: June 18, 2025

What is the potential of formyl peptide receptor 1 (FPR1) as a therapeutic target in human disease?

What is the potential of formyl peptide receptor 1 (FPR1) as a therapeutic target in human disease?

Journal: Expert opinion on therapeutic targets
Published: May 29, 2025

Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique.

Activation and signaling characteristics of the hydroxy-carboxylic acid 3 receptor identified in human neutrophils through a microfluidic flow cell technique.

Journal: Biochimica et biophysica acta. Molecular cell research
Published: December 17, 2024

LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2.

LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2.

Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: November 12, 2024

Development of a yeast-based sensor platform for evaluation of ligands recognized by the human free fatty acid 2 receptor.

Development of a yeast-based sensor platform for evaluation of ligands recognized by the human free fatty acid 2 receptor.

Journal: FEMS yeast research
Published: July 15, 2024

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

Journal: British journal of pharmacology
Published: December 20, 2023

Signaling by neutrophil G protein-coupled receptors that regulate the release of superoxide anions.

Signaling by neutrophil G protein-coupled receptors that regulate the release of superoxide anions.

Journal: Journal of leukocyte biology
Published: December 09, 2023

Larixol is not an inhibitor of Gαi containing G proteins and lacks effect on signaling mediated by human neutrophil expressed formyl peptide receptors.

Larixol is not an inhibitor of Gαi containing G proteins and lacks effect on signaling mediated by human neutrophil expressed formyl peptide receptors.

Journal: Biochemical pharmacology
Published: November 29, 2023
Showing 1-12 of 81

Last Updated: 09/26/2026